![]() |
市场调查报告书
商品编码
1904603
宠物微生物组营养市场预测至2032年:全球产品、宠物类型、剂型、成分、通路、健康用途和区域分析Pet Microbiome Based Nutrition Market Forecasts to 2032 - Global Analysis By Product, Pet Type, Form, Ingredient Source, Distribution Channel, Health Application and By Geography |
||||||
根据 Stratistics MRC 的一项研究,全球宠物微生物组营养市场预计到 2025 年价值 12.2 亿美元,预计到 2032 年将达到 22 亿美元,在预测期内复合年增长率为 8.7%。
宠物微生物组营养是指一种以科学为基础的宠物健康方法,它根据动物肠道微生物组的组成和活性来配製膳食、补充剂和功能性成分。这种方法植根于传统营养学,并融合了现代微生物学和基因组学,专注于平衡有益菌群,以支持消化功能、免疫力、新陈代谢和整体健康。透过分析微生物多样性和代谢反应,可以针对每隻宠物量身定制营养干预措施。随着研究的不断深入,微生物组营养正在重塑预防性兽医护理,将检验的餵食原则与前瞻性的精准医疗策略相结合,造福伴侣动物。
宠物人性化程度提高与健康意识增强
宠物人性化以及人们日益增强的健康意识正在推动对基于微生物组的营养解决方案的强劲需求。宠物不再只是被视为动物,而是家庭成员,这促使饲主寻求预防性和科学支持的营养方案。人们对肠道健康在免疫力、消化和寿命方面的重要作用的认识显着提高。以微生物组为中心的饮食和补充剂提供了一种积极主动的健康维护方法,而非疾病治疗,这与现代宠物护理理念完美契合,并推动了全球市场的成长。
保健品高成本
微生物组补充剂和特製宠物食品的高成本仍然是一大障碍。先进的配方工艺、高品质的菌株以及临床检验都会增加生产成本,而这些成本最终会转嫁给消费者。尤其是在发展中地区,消费者对价格的高度敏感限制了其广泛应用,儘管人们的认知度正在不断提高。高昂的价格也阻碍了消费者重复购买和长期使用。在实现规模经济和建立成本效益高的生产方法之前,价格因素很可能仍是市场渗透的一大障碍。
微生物组科学进展
微生物组科学的持续进步为市场拓展提供了巨大的机会。微生物定序、菌株鑑定和功能图谱绘製的突破,使得高度标靶的营养配方成为可能。对肠-脑和肠-免疫连结的深入理解,正将应用范围从消化扩展到行为、免疫和代谢健康领域。随着研究的深入和配方精准度的提高,企业可以开发差异化的个人化营养解决方案,从而在宠物预防和治疗护理领域开闢新的成长途径。
监管挑战
监管挑战对市场构成潜在威胁。益生菌、功能性成分和健康声明的区域监管不一致,使产品核可和商业化变得复杂。对标籤、功效检验和安全标准的严格审查增加了合规成本。此外,食品和治疗产品之间界限不清也可能延迟产品上市。成功应对这些不断变化的法规结构至关重要,违规可能会限制产品供应并阻碍创新。
新冠疫情对宠物微生物组营养市场产生了整体正面影响。疫情封锁期间宠物饲养量的激增带动了对高端营养和健康促进产品的需求。人们对免疫力和预防保健的日益关注也推动了宠物肠道健康解决方案的发展。儘管供应链中断暂时影响了生产,但电子商务的加速发展和直销模式的强化增强了市场的韧性,为疫情后的持续成长提供了支撑。
预计在预测期内,消化健康领域将占据最大的市场份额。
由于消化系统健康在宠物整体健康中扮演着核心角色,预计在预测期内,该细分市场将占据最大的市场份额。消化器官系统问题是伴侣动物最常见的健康问题之一,因此,针对肠道健康的营养解决方案的需求持续成长。以微生物组为基础的产品已显着改善了消化功能、粪便品质和营养吸收,增强了消费者的信心。强大的科学基础和快速见效的效果,使得消化系统健康成为推广以微生物组为基础的宠物营养产品的基石。
预计在预测期内,细菌菌株细分市场将呈现最高的复合年增长率。
由于对菌株特异性功效的需求不断增长,预计在预测期内,细菌菌株细分市场将呈现最高的成长率。微生物组研究的进展使得人们能够识别与免疫、消化和代谢平衡相关的特定细菌菌株。宠物饲主和兽医越来越倾向于选择经过临床检验的精准配方产品。个人化和依证营养管理的日益重要性推动了专有细菌菌株的创新,使该细分市场成为未来市场扩张的关键驱动力。
由于宠物拥有率的快速增长、都市生活方式的普及以及可支配收入的增加,亚太地区预计将在预测期内占据最大的市场份额。人们对宠物营养意识提升、兽医服务的扩展以及高端宠物食品的日益普及,都支撑了强劲的需求。中国、日本和澳洲等国家正在推动对功能性和预防性宠物营养的需求,使该地区主导。
在预测期内,北美地区预计将实现最高的复合年增长率,这主要得益于其先进的宠物医疗保健基础设施和消费者较高的健康意识。该地区的宠物饲主正积极投资以科学为基础的优质营养产品和预防性健康解决方案。主要企业的强大实力、研发的持续进步以及直销模式的普及,都进一步推动了这项成长。该地区对创新的开放态度,使得基于微生物组的营养疗法成为传统宠物护理方法的自然演进。
According to Stratistics MRC, the Global Pet Microbiome Based Nutrition Market is accounted for $1.22 billion in 2025 and is expected to reach $2.20 billion by 2032 growing at a CAGR of 8.7% during the forecast period. Pet Microbiome Based Nutrition refers to a science-driven approach to pet health that formulates diets, supplements, and functional ingredients based on the composition and activity of an animal's gut microbiome. Rooted in classical nutrition and strengthened by modern microbiology and genomics, it focuses on balancing beneficial bacteria to support digestion, immunity, metabolism, and overall wellness. By analyzing microbial diversity and metabolic responses, this approach enables targeted nutritional interventions tailored to individual pets. As research advances, microbiome-based nutrition is reshaping preventive veterinary care, blending time-tested feeding principles with forward-looking, precision health strategies for companion animals.
Rising Pet Humanization & Health Awareness
Rising pet humanization and growing health awareness are driving strong demand for microbiome-based nutrition solutions. Pets are no longer viewed merely as animals but as integral family members, encouraging owners to seek preventive, science-backed nutrition. Awareness of gut health's role in immunity, digestion, and longevity has expanded significantly. Microbiome-focused diets and supplements offer a proactive way to maintain wellness rather than treat illness, aligning perfectly with modern pet care philosophies and accelerating market growth worldwide.
High Cost of Supplements
High costs associated with microbiome-based supplements and specialized pet foods remain a key restraint. Advanced formulation processes, high-quality bacterial strains, and clinical validation increase production expenses, which are passed on to consumers. Price sensitivity, particularly in developing regions, limits widespread adoption despite rising awareness. Premium pricing also restricts repeat purchases and long-term usage. Until economies of scale and cost-efficient production methods mature, affordability will continue to challenge broader market penetration.
Advances in Microbiome Science
Ongoing advances in microbiome science present a major opportunity for market expansion. Breakthroughs in microbial sequencing, strain identification, and functional mapping are enabling highly targeted nutritional formulations. Improved understanding of gut-brain and gut-immune connections is expanding applications beyond digestion to behavior, immunity, and metabolic health. As research deepens and formulation precision improves, companies can develop differentiated, personalized nutrition solutions, opening new growth avenues across preventive and therapeutic pet care segments.
Regulatory Challenges
Regulatory challenges pose a potential threat to the market. Inconsistent regulations governing probiotics, functional ingredients, and health claims across regions complicate product approvals and commercialization. Stricter scrutiny on labeling, efficacy validation, and safety standards increases compliance costs. Additionally, unclear classification between food and therapeutic products can delay market entry. Navigating these evolving regulatory frameworks is essential, as failure to comply may restrict product availability and slow innovation.
The COVID-19 pandemic had a net positive impact on the pet microbiome-based nutrition market. A surge in pet adoption during lockdowns increased demand for premium nutrition and wellness products. Heightened focus on immunity and preventive health extended to pets, boosting interest in gut health solutions. While supply chain disruptions affected production temporarily, accelerated e-commerce adoption and direct-to-consumer models strengthened market resilience, supporting sustained post-pandemic growth.
The digestive health segment is expected to be the largest during the forecast period
The digestive health segment is expected to account for the largest market share during the forecast period, due to its central role in overall pet wellness. Digestive issues are among the most common health concerns in companion animals, driving consistent demand for gut-focused nutritional solutions. Microbiome-based products deliver visible improvements in digestion, stool quality, and nutrient absorption, strengthening consumer trust. Strong scientific backing and immediate benefits make digestive health the cornerstone of microbiome-based pet nutrition adoption.
The bacterial strains segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the bacterial strains segment is predicted to witness the highest growth rate, due to rising demand for strain-specific efficacy. Advances in microbiome research have enabled identification of targeted bacterial strains linked to immunity, digestion, and metabolic balance. Pet owners and veterinarians increasingly prefer clinically validated, precision-formulated products. As personalization and evidence-based nutrition gain importance, innovation in proprietary bacterial strains is accelerating, positioning this segment as a key driver of future market expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid growth in pet ownership, urban lifestyles, and rising disposable incomes. Increasing awareness of pet nutrition, expanding veterinary services, and growing availability of premium pet food products support strong adoption. Countries such as China, Japan, and Australia are witnessing heightened demand for functional and preventive pet nutrition, making the region a dominant force in the global microbiome-based nutrition market.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced pet healthcare infrastructure and high consumer awareness. Pet owners in the region actively invest in premium, science-backed nutrition and preventive wellness solutions. Strong presence of key players, continuous research advancements, and widespread adoption of direct-to-consumer models further accelerate growth. The region's openness to innovation positions microbiome-based nutrition as a natural evolution of traditional pet care practices.
Key players in the market
Some of the key players in Pet Microbiome Based Nutrition Market include Nestle Purina PetCare, NOW Health Group, Mars Petcare, NaturVet, Hill's Pet Nutrition, Ark Naturals Company, Nutramax Laboratories, PetAg, Inc., Zesty Paws, Fera Pets, VetriScience Laboratories, AnimalBiome, Chr. Hansen Holding A/S, ADM and Novozymes A/S.
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.